1. Home
  2. NVCR vs SID Comparison

NVCR vs SID Comparison

Compare NVCR & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • SID
  • Stock Information
  • Founded
  • NVCR 2000
  • SID 1941
  • Country
  • NVCR Switzerland
  • SID Brazil
  • Employees
  • NVCR N/A
  • SID N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • SID Steel/Iron Ore
  • Sector
  • NVCR Health Care
  • SID Industrials
  • Exchange
  • NVCR Nasdaq
  • SID Nasdaq
  • Market Cap
  • NVCR 2.3B
  • SID 2.0B
  • IPO Year
  • NVCR 2015
  • SID 1997
  • Fundamental
  • Price
  • NVCR $17.82
  • SID $1.68
  • Analyst Decision
  • NVCR Strong Buy
  • SID Strong Sell
  • Analyst Count
  • NVCR 4
  • SID 3
  • Target Price
  • NVCR $37.50
  • SID $2.40
  • AVG Volume (30 Days)
  • NVCR 795.3K
  • SID 2.5M
  • Earning Date
  • NVCR 05-01-2025
  • SID 03-12-2025
  • Dividend Yield
  • NVCR N/A
  • SID 13.22%
  • EPS Growth
  • NVCR N/A
  • SID N/A
  • EPS
  • NVCR N/A
  • SID N/A
  • Revenue
  • NVCR $605,220,000.00
  • SID $7,063,567,739.00
  • Revenue This Year
  • NVCR $3.41
  • SID $8.50
  • Revenue Next Year
  • NVCR $9.24
  • SID $5.05
  • P/E Ratio
  • NVCR N/A
  • SID N/A
  • Revenue Growth
  • NVCR 18.82
  • SID N/A
  • 52 Week Low
  • NVCR $11.70
  • SID $1.27
  • 52 Week High
  • NVCR $34.13
  • SID $3.17
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 33.96
  • SID 52.55
  • Support Level
  • NVCR $18.23
  • SID $1.71
  • Resistance Level
  • NVCR $19.06
  • SID $1.82
  • Average True Range (ATR)
  • NVCR 0.80
  • SID 0.06
  • MACD
  • NVCR 0.02
  • SID -0.00
  • Stochastic Oscillator
  • NVCR 5.57
  • SID 61.25

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. The company operate throughout the entire steel production chain, from the mining of iron ore to the production and sale of a diversified range of steel products. It operates in five segments namely, Steel, Mining, Logistics, Energy, and Cement. It generates maximum revenue from the steel segment. Geographically, it derives a majority of revenue from Asia.

Share on Social Networks: